Compare STEX & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | STEX | MYO |
|---|---|---|
| Founded | 2009 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Industrial Specialties |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 72.0M | 63.8M |
| IPO Year | 2013 | 2017 |
| Metric | STEX | MYO |
|---|---|---|
| Price | $0.49 | $1.45 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $4.64 |
| AVG Volume (30 Days) | ★ 1.1M | 322.8K |
| Earning Date | 11-13-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $18,000.00 | ★ $1,000,000,000.00 |
| Revenue This Year | N/A | $11.43 |
| Revenue Next Year | $1,314.29 | $12.29 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 40814.79 |
| 52 Week Low | $0.48 | $0.61 |
| 52 Week High | $6.50 | $1.89 |
| Indicator | STEX | MYO |
|---|---|---|
| Relative Strength Index (RSI) | 32.38 | 45.61 |
| Support Level | N/A | $1.36 |
| Resistance Level | $1.07 | $1.71 |
| Average True Range (ATR) | 0.08 | 0.12 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 3.10 | 15.00 |
Streamex Corp is a vertically integrated technology and infrastructure company. The Company is a technology company with two principal lines of business: (i) Tokenized Asset Finance, focused on digital asset and real-world asset tokenization via Streamex Exchange platform, and (ii) Biomedical Technology, focused on signal processing solutions in electrophysiology. The group provides institutional-grade solutions that bring traditional commodities and assets on-chain through secure, regulated, and yield-bearing financial instruments. It is committed to delivering transparent, scalable, and compliant digital asset solutions that bridge the gap between traditional finance and blockchain-enabled markets.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA). Geographically, it derives maximum revenue from the United States, followed by Germany, and other international.